I hammered PC on this earlier in the year on the phone. His continued response was that this was the licensee's job. I mentioned that surely there is a role for Biota to lobby governments and be proactive in this way (together with the licensee) but unfortunately, I got nowhere on this. ___________________________________________________________
For Starters BTA could improve its spin on partnering and clearly define the web link to DS for Inavir and GSK for Relenza.
BTA Price at posting:
$1.01 Sentiment: Buy Disclosure: Held